Literature DB >> 34037044

Chemical probes targeting the kinase CK2: a journey outside the catalytic box.

Jessica Iegre1, Eleanor L Atkinson1, Paul D Brear2, Bethany M Cooper1, Marko Hyvönen2, David R Spring1.   

Abstract

CK2 is a protein kinase that plays important roles in many physio-pathological cellular processes. As such, the development of chemical probes for CK2 has received increasing attention in the past decade with more than 40 lead compounds developed. In this review, we aim to provide the reader with a comprehensive overview of the chemical probes acting outside the highly-conserved ATP-site developed to date. Such probes belong to different classes of molecules spanning from small molecules to peptides, act with a range of mechanisms of action and some of them present themselves as promising tools to investigate the biology of CK2 and therefore develop therapeutics for many disease areas including cancer and COVID-19.

Entities:  

Year:  2021        PMID: 34037044     DOI: 10.1039/d1ob00257k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

Review 2.  Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms.

Authors:  Emanuela B Pucko; Robert P Ostrowski
Journal:  Pharmaceutics       Date:  2022-01-30       Impact factor: 6.321

3.  Development of small cyclic peptides targeting the CK2α/β interface.

Authors:  Eleanor L Atkinson; Jessica Iegre; Claudio D'Amore; Paul Brear; Mauro Salvi; Marko Hyvönen; David R Spring
Journal:  Chem Commun (Camb)       Date:  2022-04-12       Impact factor: 6.222

4.  Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses.

Authors:  Xuan Yang; Rebekah J Dickmander; Armin Bayati; Sharon A Taft-Benz; Jeffery L Smith; Carrow I Wells; Emily A Madden; Jason W Brown; Erik M Lenarcic; Boyd L Yount; Edcon Chang; Alison D Axtman; Ralph S Baric; Mark T Heise; Peter S McPherson; Nathaniel J Moorman; Timothy M Willson
Journal:  ACS Chem Biol       Date:  2022-06-19       Impact factor: 4.634

Review 5.  The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.

Authors:  Daniel Halloran; Venu Pandit; Anja Nohe
Journal:  J Dev Biol       Date:  2022-07-27

6.  CK2 Inhibition and Antitumor Activity of 4,7-Dihydro-6-nitroazolo[1,5-a]pyrimidines.

Authors:  Daniil N Lyapustin; Svetlana K Kotovskaya; Ilya I Butorin; Evgeny N Ulomsky; Vladimir L Rusinov; Denis A Babkov; Alexander A Pokhlebin; Alexander A Spasov; Vsevolod V Melekhin; Maria D Tokhtueva; Anna V Shcheglova; Oleg G Makeev
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.